WAVE Life Sciences's EBIT per Share for the
three
months ended in Dec. 2024 was $0.14.
Its EBIT per Share for the trailing twelve months (TTM) ended in Dec. 2024 was $-0.88.
During the past 3 years, the average EBIT per Share Growth Rate was 31.20% per year.
During the past 5 years, the average EBIT per Share Growth Rate was 36.30% per year.
During the past 10 years, the average EBIT per Share Growth Rate was 0.30% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.
The historical rank and industry rank for WAVE Life Sciences's EBIT per Share or its related term are showing as below:
WVE'
s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -146.5 Med: -0.4 Max: 45.3
Current: 31.2
During the past 12 years, the highest 3-Year average EBIT per Share Growth Rate of WAVE Life Sciences was 45.30% per year. The lowest was -146.50% per year. And the median was -0.40% per year.
WVE's 3-Year EBIT Growth Rate is ranked better than 77.9% of 1231
companies
in the Biotechnology industry
Industry Median: 7.1
vs WVE: 31.20
The historical data trend for WAVE Life Sciences's EBIT per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EBIT per Share for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.88
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
WAVE Life Sciences (NAS:WVE) EBIT per Share Explanation
EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.
WAVE Life Sciences EBIT per Share Related Terms
Thank you for viewing the detailed overview of WAVE Life Sciences's EBIT per Share provided by GuruFocus.com. Please click on the following links to see related term pages.
WAVE Life Sciences Ltd is a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines also known as oligonucleotides, targeting ribonucleic acid (RNA), to transform human health. RNA medicines platform, PRISM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Its toolkit of RNA-targeting modalities includes RNA editing, antisense silencing, and RNA interference, providing capabilities for designing and sustainably delivering candidates that optimally address disease biology. Its programs are for rare and prevalent diseases, including alpha-1 antitrypsin deficiency, obesity, Duchenne muscular dystrophy, and Huntington's disease.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
WVE has been successfully added to your 